Ksolves India Limited (BOM:543599)
India · Delayed Price · Currency is INR 315.90
-7.90 (-2.44%)
At close: Aug 1, 2025
Blueprint Medicines Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2021 |
Operating Revenue | 1,435 | 1,374 | 1,086 | 783.12 | 470.69 | 282.15 | Upgrade |
Other Revenue | 0 | 0 | - | - | - | - | Upgrade |
| 1,435 | 1,374 | 1,086 | 783.12 | 470.69 | 282.15 | Upgrade | |
Revenue Growth (YoY) | 23.29% | 26.51% | 38.72% | 66.38% | 66.82% | 178.47% | Upgrade |
Cost of Revenue | 690.46 | 635.6 | 459.09 | 345.7 | 205.06 | 115.55 | Upgrade |
Gross Profit | 744.82 | 738.74 | 627.28 | 437.42 | 265.63 | 166.6 | Upgrade |
Selling, General & Admin | - | - | 27.8 | 11.54 | 11.71 | 8.95 | Upgrade |
Other Operating Expenses | 286.9 | 260.13 | 131.65 | 95.2 | 50.53 | 31.88 | Upgrade |
Operating Expenses | 313.79 | 282.29 | 168.11 | 112.21 | 67.15 | 45.18 | Upgrade |
Operating Income | 431.04 | 456.44 | 459.17 | 325.21 | 198.48 | 121.42 | Upgrade |
Interest Expense | -5.45 | -2.84 | -0.56 | -0.31 | -0.17 | -0.28 | Upgrade |
Interest & Investment Income | - | - | 3.39 | 6.22 | 12.26 | 1.99 | Upgrade |
Currency Exchange Gain (Loss) | - | - | -3.33 | -1.78 | -1.82 | -3.65 | Upgrade |
Other Non Operating Income (Expenses) | 4.45 | 4.45 | - | 0.04 | 0.4 | 0.1 | Upgrade |
EBT Excluding Unusual Items | 430.04 | 458.05 | 458.67 | 329.38 | 209.14 | 119.58 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | -0.02 | - | - | Upgrade |
Pretax Income | 430.04 | 458.05 | 458.67 | 329.36 | 209.14 | 119.58 | Upgrade |
Income Tax Expense | 112.1 | 114.85 | 117.13 | 82.15 | 50.2 | 30.2 | Upgrade |
Net Income | 317.93 | 343.2 | 341.54 | 247.2 | 158.94 | 89.38 | Upgrade |
Net Income to Common | 317.93 | 343.2 | 341.54 | 247.2 | 158.94 | 89.38 | Upgrade |
Net Income Growth | -10.48% | 0.49% | 38.16% | 55.53% | 77.82% | 1217.98% | Upgrade |
Shares Outstanding (Basic) | 24 | 24 | 24 | 24 | 24 | 24 | Upgrade |
Shares Outstanding (Diluted) | 24 | 24 | 24 | 24 | 24 | 24 | Upgrade |
Shares Change (YoY) | 0.07% | 0.03% | - | - | - | 586.89% | Upgrade |
EPS (Basic) | 13.40 | 14.47 | 14.40 | 10.43 | 6.70 | 3.77 | Upgrade |
EPS (Diluted) | 13.40 | 14.47 | 14.40 | 10.43 | 6.70 | 3.77 | Upgrade |
EPS Growth | -10.54% | 0.46% | 38.16% | 55.53% | 77.82% | 91.89% | Upgrade |
Free Cash Flow | - | 268.81 | 310.57 | 201.27 | 96.52 | 47.94 | Upgrade |
Free Cash Flow Per Share | - | 11.33 | 13.10 | 8.49 | 4.07 | 2.02 | Upgrade |
Dividend Per Share | 11.500 | 15.500 | 9.750 | 11.750 | 2.875 | 2.500 | Upgrade |
Dividend Growth | - | 58.97% | -17.02% | 308.70% | 15.00% | - | Upgrade |
Gross Margin | 51.89% | 53.75% | 57.74% | 55.86% | 56.44% | 59.05% | Upgrade |
Operating Margin | 30.03% | 33.21% | 42.27% | 41.53% | 42.17% | 43.04% | Upgrade |
Profit Margin | 22.15% | 24.97% | 31.44% | 31.57% | 33.77% | 31.68% | Upgrade |
Free Cash Flow Margin | - | 19.56% | 28.59% | 25.70% | 20.51% | 16.99% | Upgrade |
EBITDA | 456.57 | 478.6 | 467.83 | 330.68 | 203.39 | 125.24 | Upgrade |
EBITDA Margin | 31.81% | 34.82% | 43.06% | 42.23% | 43.21% | 44.39% | Upgrade |
D&A For EBITDA | 25.53 | 22.16 | 8.66 | 5.47 | 4.91 | 3.81 | Upgrade |
EBIT | 431.04 | 456.44 | 459.17 | 325.21 | 198.48 | 121.42 | Upgrade |
EBIT Margin | 30.03% | 33.21% | 42.27% | 41.53% | 42.17% | 43.04% | Upgrade |
Effective Tax Rate | 26.07% | 25.07% | 25.54% | 24.94% | 24.00% | 25.26% | Upgrade |
Revenue as Reported | 1,440 | 1,379 | 1,090 | 789.37 | 483.34 | 284.25 | Upgrade |
Advertising Expenses | - | - | 4.29 | 2.75 | 4.13 | 0.66 | Upgrade |
Updated Jan 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.